Grifols S.A. 3.875% | - | 1.00% | - | - | 3,930,000 |
Organon & Co 2.875% | - | 0.91% | - | - | 3,509,000 |
| XS1793255941=TX | 0.80% | 101.83 | +0.04% | 2,971,000 | |
MPT Operating Partnership LP / MPT Finance Corporation 7% | - | 0.79% | - | - | 2,848,000 |
Vodafone Group PLC | - | 0.75% | - | - | 2,807,000 |
| XS1645722262=TX | 0.74% | 98.54 | +0.06% | 2,807,000 | |
Vodafone Group PLC | - | 0.74% | - | - | 2,870,000 |
| XS2301390089=TX | 0.72% | 97.200 | +0.02% | 2,807,000 | |
Amber Finco PLC 6.625% | - | 0.71% | - | - | 2,513,000 |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | - | 0.70% | - | - | 2,597,000 |
Multi Units Luxembourg - Lyxor iBoxx EUR Liquid High Yield BB UCITS ETF is an exchange traded fund launched and managed by Lyxor International Asset Management S.A. It invests in the fixed income markets of Europe. The fund uses derivatives such as swaps to invest in Euro denominated, fixed-rate corporate bonds with a minimum time to maturity of one year. It invests in high yield securities that are rated as between BB+ and BB- by S&P and Fitch and Ba1 and Ba3 by Moody’s. The fund seeks to replicate the performance of the Markit iBoxx HY Corporates BB Cum Crossover Top 50 Total Return Index, by employing synthetic replication methodology. Multi Units Luxembourg - Lyxor iBoxx EUR Liquid High Yield BB UCITS ETF was formed on April 10, 2015 and is domiciled in Luxembourg.